ArticleCancer gene therapy2022

Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1.

Yunfu Deng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.